April 23, 2014 — Manhattan Diagnostic Radiology (MDR), a wholly owned subsidiary of RadNet Inc., announced that 3-D mammography breast cancer screening is now available at its 66th Street location.

MDR is the first freestanding, full-service radiology provider in Manhattan to offer this 3-D technology. Also known as breast tomosynthesis, this newest software makes 2-D images from a 3D scan, an upgrade only recently approved for use by the U.S. Food and Drug Administration (FDA). Three-dimensional mammography will eventually allow for faster scan times and reduced radiation exposure.

Standard 2-D mammograms take two images of each breast, one horizontal and one vertical. With 3-D mammography, the X-ray machine swings in an arc, acquiring approximately 60 individual millimeter-thin section images. The radiologist then views these images on a high-resolution computer monitor.

"This new way of performing mammograms improves our ability to find cancers, particularly in women with dense breast tissue in whom a small malignancy can be difficult to detect. Already in our early experience with this technology, we have discovered unsuspected cancers, which I am convinced would not have been detected with 2-D mammography alone. Three-dimensional mammography also reduces the number of false positive findings, which cuts back on additional testing and reduces anxiety," said Melissa Scheer, M.D., breast-imaging specialist at MDR.

Since insurance does not yet cover the cost of 3-D mammography, there will be a charge for the procedure at MDR.

For more information: www.radnet.com


Related Content

News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now